STOCK TITAN

POMDOCTOR to swap 10 ADSs for 3 post-split shares

TranShare Corporation has been appointed U.S. transfer agent for the Class A ordinary shares.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

POMDOCTOR Ltd (POM) has commenced termination of its American Depositary Receipt program and related deposit agreement, with termination expected before market opening on October 21, 2026. The company plans to list Class A ordinary shares directly on Nasdaq in place of the ADSs, with trading expected to begin that day under POM.

At the same time as the termination, the company will consolidate each class of ordinary shares at a 10-for-1 ratio. In the mandatory exchange, every 10 ADSs will be exchanged for 3 post-consolidation Class A ordinary shares. The board approved the actions on September 3, 2026, and shareholders approved them on a non-binding advisory basis on September 30, 2026.

Share consolidation ratio 10 ordinary shares into 1 ordinary share Applies to each of the Class A and Class B ordinary shares
ADS exchange ratio 10 ADSs for 3 post-consolidation Class A ordinary shares Mandatory exchange
Expected program termination Before market opening on October 21, 2026 ADR Program and Deposit Agreement
Expected direct trading start October 21, 2026 Class A ordinary shares on Nasdaq under POM
American Depositary Shares technical
"holders and beneficial owners of the American Depositary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
Deposit Agreement technical
"termination of the related deposit agreement"
A deposit agreement is a written contract between a customer and a financial institution that outlines the terms for opening and maintaining a deposit account, such as a savings or checking account. It explains important details like how funds can be accessed, any fees involved, and the institution’s responsibilities. For investors, understanding this agreement is important because it clarifies their rights and the rules governing their deposited funds.
Mandatory Exchange technical
"the “Mandatory Exchange”"
A mandatory exchange is a contractual rule that forces one type of security to be swapped for another—most often debt being converted into stock—at a set date or when specific conditions occur. Investors care because it changes who owns the company and its financial shape: creditors become shareholders, debt levels fall, and existing owners can be diluted, so the company's risk profile, voting control and future earnings per share can shift like swapping a loan for a roll of stock certificates.
Share Consolidation technical
"the “Share Consolidation”"
Share consolidation is a process where a company reduces the total number of its shares by combining multiple existing shares into a smaller number of higher-value shares. This can make each share more expensive and potentially improve the company’s image. For investors, it often means their ownership remains the same, but the value of each share increases, which can influence how the stock is perceived and traded.
Split Ratio 1-for-10 reverse split
Effective Date October 21, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What will happen to POM ADS holders?

The ADSs will be mandatorily cancelled and exchanged for Class A ordinary shares under the Deposit Agreement; each holder of 10 ADSs will receive 3 post-consolidation Class A ordinary shares.

When will POM ordinary shares begin trading directly on Nasdaq?

Trading in the Class A ordinary shares is expected to begin when the market opens on October 21, 2026, under the symbol POM.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of October 2026

 

Commission File Number 001-42749

 

POMDOCTOR LIMITED

 

Yongxu Industrial Park

No. 19-23 Hejing Road, Dongsha Street

Liwan District, Guangzhou

People’s Republic of China 510000

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F             ☐ Form 40-F

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Termination of American Depositary Receipt Program and Trade Class A Ordinary Shares on Nasdaq

 

As previously approved by the board of directors of POMDOCTOR LIMITED (the “Company”) on September 3, 2026 and approved by the Company’s shareholders on a non-binding advisory basis at the extraordinary general meeting of shareholders held on September 30, 2026, the Company today announced that it has commenced to terminate its American Depositary Receipt program (the “ADR Program”), including the termination of the related deposit agreement, as amended, and list the Company’s Class A ordinary shares directly on The Nasdaq Stock Market LLC (“Nasdaq”). The ADR Program to be terminated was established pursuant to the Deposit Agreement, dated October 9, 2025, as amended, among the Company, Citibank, N.A. (the “Depositary”) and the holders and beneficial owners of the American Depositary Shares (“ADSs”) issued thereunder (the “Deposit Agreement”).

 

The ADR Program and the Deposit Agreement are expected to terminate prior to the opening of the market on October 21, 2026. At that time, the Company’s ADSs will be mandatorily cancelled and exchanged for the Class A ordinary shares to be distributed to the ADS holders (the “Mandatory Exchange”) according to the Deposit Agreement.

 

Simultaneously with the effectiveness of the termination of the ADR Program, the Company will effect a share consolidation of its Class A ordinary shares and Class B ordinary shares, pursuant to which every ten (10) ordinary shares of each class will be consolidated into one (1) ordinary share of the same class (the “Share Consolidation”). As a result of the Share Consolidation and Mandatory Exchange, each holder of ten (10) ADSs will receive three (3) post-Share Consolidation Class A ordinary shares. In connection with the termination of the ADR Program and Share Consolidation, the Company plans to list its Class A ordinary shares for trading on Nasdaq in substitution for the ADSs. The Company’s Class A ordinary shares are expected to commence trading on Nasdaq when the market opens on October 21, 2026 under the symbol “POM” with the new CUSIP number G7166T112.

 

The Company has appointed TranShare Corporation as its transfer agent in the United States for its Class A ordinary shares.

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  POMDOCTOR LIMITED
   
  By: /s/ Zhenyang Shi
  Name: Zhenyang Shi
  Title: Chairman and Chief Executive Officer

 

Date: October 19, 2026

 

2

 

Keep reading